Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Cyclin A is a good marker for breast cancer tumor proliferation and prognosis
November 10th, 2005
Cyclin A is a good marker for breast cancer tumor proliferation and prognosis. According to recent research from Finland, "We wanted to study cyclin A as a marker for prognosis and chemotherapy response. A total of 283 women with metastatic breast cancer were initially enrolled in a randomized multicenter trial comparing docetaxel to sequential methotrexate-fluorouracil (MF) in advanced breast cancer after anthracycline failure." "Paraffin-embedded blocks of the primary tumor were available for 96 patients (34%). The proportion of cells expressing cyclin A was determined by immunohistochemistry using a mouse monoclonal antibody to human cyclin A....
Source: Women's Health Weekly (2005-11-10)
|
